[The epidemiological risk factors related to labor migration].

The prevention of diseases among migrants becomes a serious problem of public health of subjects of the Russian Federation. The system of public sanitary epidemiological inspection in the field of biological security of the Russian Federation demands a permanent enhancement.

[Efficiency of partial pneumonectomies in patients with multidrug-resistant tuberculosis].

The immediate results of partial resections were analyzed in 120 patients with drug-resistant pulmonary tuberculosis, among whom 70 patients had multidrug resistance. A complete clinical effect (abacillation and no decay cavities) was achieved in 117 (97.5%) patients, including in 67 (95.7%) patients with multidrug resistance who showed improvement in 3 (2.5%) cases, fatal outcomes being absent.

[Some blood indices and the leukocytic index of intoxication in tuberculosis, pneumonias, abscesses, and cancer of the lung].

Examining the values of hemoglobin, red and white blood cells, differential count, and leukocytic index of intoxication (LII) in patients with tuberculosis, abscesses, pneumonias, and cancer of the lung indicated that in accordance with clinical and X-ray findings, LII and the count of lymphocytes reflected the degree of patients' health status to the greatest extent. These blood values were of the greatest prognostic value. In lung cancer, LII increased only when inflammatory and purulent complications occurred. Erythrocyte sedimentation rates had a greater tendency to increase in nonspecific processes, which may be occasionally of differential diagnostic value.

[Use of the plant hepatoprotector Galstena tuberculostatics-induced hepatic lesions: experimental and clinical study]. / Ispol'zovanie gepatoprotektora rastitel'nogo proiskhozhdeniia galsteny pri porazheniiakh pecheni tuberkulostatikami (éksperimental'no-klinicheskoe issledovanie).

The efficiency of the use of the natural drug Galstena (Richard Bittner GmbH) was experimentally and clinically studied on a model of damage induced by toxic doses of tuberculostatics (rifampicin, isoniazid, pyrazinamide) in laboratory rats and in patients with different forms of pulmonary tuberculosis and with hepatitis caused by specific antituberculous drug therapy, who were treated at the Clinic of Phthiziology. Galstena was found to have marked hepatoprotective properties and to be able to prevent renal and pancreatic disorders. The drug also showed an antioxidative activity. The use of Galstena in patients with pulmonary tuberculosis substantially reduced the magnitude of clinical and laboratory signs of drug-induced hepatic damage.